Learning more from the inter-rater reliability of interstitial fibrosis assessment beyond just a statistic

Peir-In Liang1, Wei-Chou Lin2, Mei-Chin Wen3

  • 1Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Scientific Reports
|August 15, 2023
PubMed

Insights

Renal pathologists show poor agreement in assessing interstitial fibrosis, with significant deviations expected in over a third of cases. This variability impacts patient classification, especially in conditions like IgA nephropathy.

Area of Science:

  • Nephrology
  • Pathology
  • Medical Statistics

Background:

  • Interstitial fibrosis assessment by renal pathologists lacks consistent agreement.
  • Variability in assessment may lead to misclassification and impact patient management.

Purpose of the Study:

  • To investigate the properties of interstitial fibrosis assessment variability.
  • To infer the potential clinical impact of this variability.

Main Methods:

  • Assessed 50 kidney biopsies with 9 renal pathologists.
  • Used intraclass correlation coefficients (ICCs) and kappa statistics.
  • Applied regression models to estimate deviation probabilities and identify causes of variation.

Main Results:

  • Inter-rater reliability ranged from poor to good (ICCs 0.48–0.90).
  • Agreement was lowest for moderate interstitial fibrosis.
  • 33.5% of assessments were expected to deviate significantly from true values.
  • Assessment variation correlated with interstitial inflammation variation (r²=32.1%).
  • IgA nephropathy interstitial fibrosis scores had an expected misclassification rate of 21.9%.

Conclusions:

  • Interstitial fibrosis assessment exhibits significant inter-rater variability.
  • Novel analytical approaches revealed previously unrecognized patterns in pathologist practice.
  • This variability has potential clinical implications for patient diagnosis and treatment stratification.